Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVIDĀ19
Crossref DOI link: https://doi.org/10.1038/s41392-020-00374-6
Published Online: 2020-11-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abd El-Aziz, Tarek Mohamed
Al-Sabi, Ahmed
Stockand, James D.
Text and Data Mining valid from 2020-11-03
Version of Record valid from 2020-11-03
Article History
Received: 10 October 2020
Revised: 15 October 2020
Accepted: 16 October 2020
First Online: 3 November 2020
Competing interests
: The authors declare no competing interests.